Hem › Diffust storcelligt B-cellslymfom › Texas › Dallas
Kliniska studier för Diffust storcelligt B-cellslymfom i Dallas, TX
13 studier för Diffust storcelligt B-cellslymfom söker deltagare vid platser i och runt Dallas (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
RekryterarFas 2
- Texas Oncology - Dallas Fort Worth, Dallas
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
RekryterarFas 3
- Texas Oncology - DFW ( Site 8000), Dallas
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
RekryterarFas 2
- UT Southwestern Medical Center ( Site 0190), Dallas
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RekryterarFas 1
- Texas Oncology - DFW (Sammons CC), Dallas
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RekryterarFas 1
- University of Texas Southwestern, Dallas
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RekryterarFas 1/2
- Baylor University Medical Center, Dallas
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
RekryterarObservationsstudie
- UT Southwestern Medical Center, Dallas
DALY II USA/ MB-CART2019.1 for DLBCL
RekryterarFas 2
- UT Southwestern Medical Center, Dallas
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
RekryterarFas 2
- University of Texas Southwestern Medical Center, Dallas
IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL
RekryterarFas 1/2
- University of Texas Southwestern Medical Center, Dallas
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
RekryterarFas 1/2
- University of Texas(UT) Southwestern-Children's Medical Center, Dallas
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RekryterarFas 1
- University of Texas Southwestern Medical Center, Dallas
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
RekryterarFas 1/2
- UT Southwestern Medical Center, Dallas
Diffust storcelligt B-cellslymfom-studier i andra städer
- New York City, NY21 studier
- Baldwin Park, CA19 studier
- Chicago, IL18 studier
- Houston, TX17 studier
- Los Angeles, CA17 studier
- Boston, MA16 studier
- Milwaukee, WI16 studier
- Nashville, TN15 studier
- Portland, OR15 studier
- Philadelphia, PA15 studier
- Durham, NC14 studier
- Seattle, WA12 studier
Andra studier i Dallas
- Bröstcancer55 studier
- Icke-småcellig lungcancer52 studier
- Metastaserande cancer42 studier
- Hjärtsvikt42 studier
- Cancer (alla typer)37 studier
- Prostatacancer36 studier
- Kolorektal cancer33 studier
- Övervikt30 studier
- Äggstockscancer28 studier
- Blåscancer27 studier
- Lungcancer27 studier
- Endometriecancer24 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.